Actavis and equivalence – where are we now?

Logo
Presented by

Douglas Drysdale, partner, HGF

About this talk

The UK Supreme Court's 2017 decision in Actavis v Eli Lilly introduced a doctrine of equivalents into UK law. In this webinar, we'll discuss the implications of that decision and look at how it is being applied in other cases in the UK courts.
Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (73)
Subscribers (10991)
Content for the home of World IP Review and Life Sciences IP Review